Table of Contents
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 14
2 Introduction 17
2.1 What Is This Report About? 17
2.2 Definitions
17
2.2.1 Nephrology and Urology Devices 17
3 Healthcare Sector Review
20
3.1 Healthcare Expenditure 20
3.2 Healthcare Infrastructure 25
3.2.1 Healthcare Personnel Data 27
3.2.2 Healthcare Facilities Data 30
4 Nephrology and Urology Devices in United States 32
4.1 Nephrology and
Urology Devices Overall Revenues (2000-2012) 32
4.2 Nephrology and Urology
Devices Overall Volume (2000-2012) 38
4.3 Nephrology and Urology Devices
Overall Company Share (2005-2006) 40
5 Incontinence Devices in United
States 41
5.1 Incontinence Devices Overall Revenue (2000-2012) 41
5.1.1 Protective Garments for Incontinence Overall Revenues (2000-2012) 45
5.1.2 Urinary Catheters Overall Revenues (2000-2012) 47
5.1.3 Urine Bags
Overall Revenues (2000-2012) 49
5.2 Incontinence Devices Overall Volume
(2000-2012) 51
5.2.1 Protective Garments for Incontinence Overall Volume
(2000-2012) 53
5.2.2 Urine Bags Overall Volume (2000-2012) 55
5.2.3
Urinary catheters Overall Volume (2000-2012) 57
5.3 Incontinence Devices
Average Price (2000-2012) 59
5.3.1 Protective Garments for Incontinence
Average Price (2000-2012) 59
5.3.2 Urinary Catheters Average Price
(2000-2012) 61
5.3.3 Urine Bags Average Price (2000-2012) 63
5.4
Incontinence Devices Distribution Share (2005-2006) 65
5.4.1 Incontinence
Devices Company Share 66
6 Renal Dialysis in United States 67
6.1
Renal Dialysis Equipment Overall Revenue (2000-2012) 67
6.1.1 Peritoneal
Dialysis Solutions Overall Revenues (2000-2012) 71
6.1.2 Hemodialysis
Machines Overall Revenues (2000-2012) 73
6.1.3 Continuous Renal
Replacement Therapy Machines Overall Revenues (2000-2012) 75
6.1.4
Dialysis Accessories Overall Revenues (2000-2012) 77
6.2 Renal Dialysis
Equipment Overall Volume (2000-2012) 89
6.2.1 Dialysis Accessories Overall
Volume (2000-2012) 90
6.2.2 Continuous Renal Replacement Therapy Machines
Overall Volume (2000-2012) 102
6.2.3 Hemodialysis Machines Overall Volume
(2000-2012) 104
6.3 Renal Dialysis Equipment Average Price (2000-2012)
106
6.3.1 Hemodialysis Machines Average Price (2000-2012) 106
6.3.2
Continuous Renal Replacement Therapy Machines Average Price (2000-2012)
108
6.3.3 Dialysis Accessories Average Price (2000-2012) 110
6.4 Renal
Dialysis Equipment Distribution Share (2005-2006) 120
6.5 Renal Dialysis
Equipment Company Share (2005-2006) 121
7 Lithoripters in United States
122
7.1 Lithotripters Overall Revenue (2000-2012) 122
7.2
Lithotripters Overall Volume (2000-2012) 124
7.3 Lithotripters Average
Price (2000-2012) 126
7.4 Lithotripters Distribution Share (2005-2006)
128
7.5 Lithotripters Company Share (2005-2006) 129
8 Baxter
International Company Profile 130
8.1 Company Overview 130
8.2
Business Overview 130
8.2.1 BioScience 130
8.2.2 Medication Delivery
130
8.2.3 Renal 131
8.2.4 Products 131
8.2.5 History 132
8.3
Value Chain Analysis 135
8.3.1 Manufacturing 135
8.3.2 Product
Development 136
8.3.3 Sales and Marketing 136
8.4 SWOT Analysis
137
8.4.1 Baxter International Inc. Strengths 137
8.4.2 Baxter
International Inc. Weaknesses 138
8.4.3 Baxter International Inc.
Opportunities 138
8.4.4 Baxter International Inc. Threats 139
8.5
Financial and Operational Review 140
8.6 Locations And Subsidiaries
141
8.7 Baxter International Inc. Pipeline Products 143
8.7.1
Next-Generation Home Hemodialysis Machine 143
9 Kimberly-Clark Corporation
Company Profile 145
9.1 Company Overview 145
9.2 Business Overview
145
9.2.1 Consumer Tissue 145
9.2.2 Healthcare 145
9.2.3 K-C
Professional & Other 146
9.2.4 Personal Care 147
9.2.5 Products
147
9.2.6 History 147
9.3 Value Chain Analysis 150
9.3.1
Manufacturing 151
9.3.2 Product Development 151
9.3.3 Sales and
Marketing 151
9.4 SWOT Analysis 151
9.4.1 Kimberly-Clark Corporation
Strengths 152
9.4.2 Kimberly-Clark Corporation Weaknesses 153
9.4.3
Kimberly-Clark Corporation Opportunities 153
9.4.4 Kimberly-Clark
Corporation Threats 153
9.5 Financial and Operational Review 154
9.6
Locations And Subsidiaries 155
10 Covidien Ltd./Tyco Healthcare Company
Profile 157
10.1 Company Overview 157
10.2 Business Overview 157
10.2.1 Imaging Solutions 157
10.2.2 Medical Devices 158
10.2.3 Medical
Supplies 158
10.2.4 Pharmaceutical Products 159
10.2.5 Retail Products
159
10.2.6 Major Products and Services 160
10.2.7 History 161
10.3
Value Chain Analysis 161
10.3.1 Manufacturing 162
10.3.2 Product
Development 162
10.3.3 Sales and Marketing 163
10.4 SWOT Analysis
164
10.4.1 Covidien Ltd./Tyco Healthcare Strengths 164
10.4.2 Covidien
Ltd./Tyco Healthcare Weaknesses 165
10.4.3 Covidien Ltd./Tyco Healthcare
Opportunities 166
10.4.4 Covidien Ltd./Tyco Healthcare Threats 166
10.5 Financial and Operational Review 168
10.5.1 Financial Statements
168
10.5.2 Financial Ratios 169
10.5.3 Share Holding Structure 170
10.6 Locations And Subsidiaries 170
10.7 Covidien Ltd./Tyco Healthcare
Pipeline Products 172
10.7.1 PleuraSeal Lung Sealant System 172
10.7.2
Sandman Intro CPAP Device 173
11 C.R. Bard, Inc. Company Profile 175
11.1 Company Overview 175
11.2 Business Overview 175
11.2.1 Oncology
Product Line 175
11.2.2 Other Products Product Line 175
11.2.3
Surgical Specialties Product Line 175
11.2.4 Urology Product Line 176
11.2.5 Vascular Product Line 176
11.2.6 Major Products and Services
176
11.2.7 History 177
11.3 Value Chain Analysis 179
11.3.1
Manufacturing 179
11.3.2 Product Development 179
11.3.3 Sales and
Marketing 180
11.4 SWOT Analysis 181
11.4.1 C.R. Bard, Inc. Strengths
181
11.4.2 C.R. Bard, Inc. Weaknesses 182
11.4.3 C.R. Bard, Inc.
Opportunities 182
11.4.4 C.R. Bard, Inc. Threats 183
11.5 Financial
and Operational Review 184
11.5.1 Financial Statements 184
11.5.2
Financial Ratios 185
11.5.3 Share Holding Structure 186
11.6 Locations
And Subsidiaries 186
11.7 C.R. Bard, Inc. Pipeline Products 189
11.7.1
VIVEXX Carotid Stent 189
11.7.2 Bard Pulsed RF Ablation System 191
11.7.3 BARD HD MESH Ablation System 192
11.7.4 Bard Scorpion Ablation
Catheter 193
11.7.5 BARD HD MESH Mapper Catheter 193
12 Fresenius
Medical Care AG & Co. KGaA Company Profile 195
12.1 Company Overview
195
12.2 Business Overview 195
12.2.1 Dialysis Care Segment 195
12.2.2 Dialysis Products Segment 196
12.2.3 Major Products and Services
197
12.2.4 History 197
12.3 Value Chain Analysis 199
12.3.1
Manufacturing 199
12.3.2 Product Development 200
12.3.3 Sales and
Marketing 200
12.4 SWOT Analysis 201
12.4.1 Fresenius Medical Care AG
& Co. KGaA Strengths 201
12.4.2 Fresenius Medical Care AG & Co. KGaA
Weaknesses 202
12.4.3 Fresenius Medical Care AG & Co. KGaA Opportunities
203
12.4.4 Fresenius Medical Care AG & Co. KGaA Threats 203
12.5
Financial and Operational Review 205
12.5.1 Financial Statements 205
12.5.2 Financial Ratios 206
12.6 Locations And Subsidiaries 207
13
Regulation System 208
13.1 Medical Equipment Approval Process 208
13.1.1 Pre-market Approval Process 209
13.1.2 Intended use and Indications
for use 209
13.1.3 Predicate Device 209
13.1.4 Safe and Effective
210
20.1.1 Other Category Devices 212
20.1.2 Post-Market Approval
Process 213
25.1.1 Compliance and Enforcement 213
25.1.2 Registration
Fee 214
25.1.3 Approval Time 214
26 Pricing and Reimbursement 215
26.1 Government Policies 215
30.1 Private Insurance 216
38.1 Diagnosis
Related Groups (DRG) 217
39 Distribution Structure 218
39.1
Distribution Structure 218
40 Financial Deals Landscape 219
40.1
Acquisition 219
40.1.1 Fresenius Medical Acquires Renal Solutions 219
40.1.2 NxStage Medical Acquires Medisystems 220
40.2 Venture Financing
222
40.2.1 EMKinetics Secures $0.5 Million In Series A Financing 222
40.2.2 Percutaneous Systems Secures $6.3 Million In Series D Financing 223
40.2.3 Pluromed Secures $4 Million In Series B Financing 224
40.2.4
Hemosphere (formerly GraftCath) Secures $12 Million In Series D Financing
226
40.2.5 GraftCath Secures $12 Million In Series D Round Of Financing
227
40.2.6 Hemosphere (formerly GRAFTcath) Secures $2.9 Million In Series
C Financing 228
40.2.7 Flowmedica Secures $2.6 Million In Venture
Financing 229
40.3 IPO 230
40.3.1 NxStage Medical Completes Private
Placement Of $43 Million 230
40.3.2 MedaSorb Technologies Completes
Private Placement Of $4.45 Million 232
40.3.3 Rockwell Medical
Technologies Completes Private Placement Of $12.95 Million 234
40.3.4
Uroplasty Completes Public Offering Of $5.13 Million 235
40.3.5 BioForm
Completes Initial Public Offering Of $92 Million 236
40.3.6 BioForm
Completes $92 Million IPO 238
40.4 Debt Offerings 239
40.4.1
ProUroCare Medical Completes $0.24 Million Private Placement 239
40.4.2
ProUroCare Medical Completes Private Placement Of $1.05 Million 241
41
Recent Developments 243
41.1 Strategy And Business Planning 243
41.1.1
Sep 02, 2008: Navilyst Medical Eyes Expansion 243
41.1.2 Jul 31, 2008: CRH
Opens New Center In Virginia 243
41.1.3 May 09, 2008: CRH Opens New Center
In Dallas 244
41.1.4 Apr 21, 2008: CRH Opens New Center In Chicago 244
41.1.5 Apr 01, 2008: Texas Instruments And IIT Kharagpur To Collaborate On
Medical Technology Research 244
41.2 Research And Development 245
41.2.1 Apr 01, 2008: Texas Instruments And IIT Kharagpur To Collaborate On
Medical Technology Research 245
41.3 Corporate Communications 245
41.3.1 Jul 23, 2008: Tengion Appoints VP, Marketing And Commercial Planning
245
41.3.2 Jul 18, 2008: Texas Instruments Elects New Board Member 246
41.3.3 Apr 21, 2008: Nephros Appoints Vice President, Marketing And Business
Development 246
41.3.4 Apr 16, 2008: Urologix Announces Executive Changes
246
41.3.5 Apr 07, 2008: Boston Scientific Appoints EVP, Secretary and
General Counsel 247
41.3.6 Mar 31, 2008: NxStage Appoints Senior Vice
President, Manufacturing Operations 247
41.3.7 Mar 19, 2008: Aethlon
Appoints Director, Investor Relations 247
41.4 Legal and Regulatory
248
41.4.1 Aug 08, 2008: Boston Scientific Receives Subpoenas 248
41.4.2 Jul 30, 2008: US District Court Rules In Favor Of Bard On Patent
Violation Suit Against Gore 248
41.4.3 Jun 17, 2008: Johnson & Johnson
Resolves Lawsuit With American Red Cross 248
41.5 Government and Public
Interest 249
41.5.1 Jun 26, 2008: Complications Of PP Surgery 249
41.6
Product News 250
41.6.1 Aug 22, 2008: Ash Access Technology Completes
AZEPTIC Trial For Zuragen Injection 250
41.7 Clinical Trials 250
41.7.1 Aug 22, 2008: Ash Access Technology Completes AZEPTIC Trial For Zuragen
Injection 250
42 Appendix 251
42.1 Methodology 251
42.2 Coverage
252
42.3 Secondary Research 252
42.4 Primary Research 253
42.5
Models 253
42.6 Forecasts 254
42.7 Expert Panels 254
42.8 Contact
Us 255
42.9 Disclaimer 255
1.1 List of Tables
Table 1: United
States Healthcare Expenditure, 2003-2010 21
Table 2: United States
Healthcare Expenditure by Age (per person), 2000-2003 22
Table 3: United
States Healthcare Expenditure by Sex (per person), 2000-2003 22
Table 4:
United States Healthcare Expenditure by Race (per person), 2000-2003 22
Table 5: United States Personal Healthcare Expenditure by Type, 2000-2004
23
Table 6: United States Personal Healthcare Expenditure by Source,
2000-2004 24
Table 7: Total Number of Doctors in the United States,
2003-2010 27
Table 8: Number of Doctors by Specialty in the United States,
2003-2010 28
Table 9: Doctors by Region (Number per 10,000 Civilian
Population), 2002-2004 29
Table 10: Doctors by Region (Number per 10,000
Civilian Population), 2002-2004 (Cont.) 30
Table 11: Total Hospitals in
the United States, 2000-2004 30
Table 12: Community Hospitals by Number of
Beds in the United States, 2000-2004 31
Table 13: Number of Hospital Beds
in the United States, 2000-2004 31
Table 14: Number of Hospital Beds by
Range in the United States, 2000-2004 31
Table 15: Nephrology and Urology
Devices, United States, Overall Revenues ($ mn), 2000-2012 32
Table 16:
Nephrology and Urology Devices, United States, Overall Revenues ($ mn),
Historic, 2000-2007 33
Table 17: Nephrology and Urology Devices, United
States, Overall Revenues ($ mn), Forecast, 2007-2012 34
Table 18:
Nephrology and Urology Devices, United States, Category Revenues ($ mn),
2000-2012 35
Table 19: Nephrology and Urology Devices, United States,
Category Revenues ($ mn), Historic, 2000-2007 36
Table 20: Nephrology and
Urology Devices, United States, Category Revenues ($ mn), Forecast, 2007-2012
37
Table 21: Nephrology and Urology Devices, United States, Category
Volume (Units), 2000-2012 38
Table 22: Nephrology and Urology Devices,
United States, Category Volume (Units), Historic, 2000-2007 38
Table 23:
Nephrology and Urology Devices, United States, Category Volume (Units),
Forecast, 2007-2012 39
Table 24: Nephrology and Urology Devices in United
States, Company Share by Revenue ($ mn), 2005-2006 40
Table 25:
Incontinence Devices, United States, Overall Revenues ($ mn), Historic,
2000-2007 41
Table 26: Incontinence Devices, United States, Overall
Revenues ($ mn), Forecast, 2007-2012 42
Table 27: Incontinence Devices,
United States, Revenue by Segment ($ mn), Historic, 2000-2007 43
Table 28:
Incontinence Devices, United States, Revenue by Segment ($ mn), Forecast,
2007-2012 44
Table 29: Protective Garments for Incontinence, United
States, Overall Revenues ($ mn), Historic, 2000-2007 45
Table 30:
Protective Garments for Incontinence, United States, Overall Revenues ($ mn),
Forecast, 2007-2012 46
Table 31: Urinary Catheters, United States, Overall
Revenues ($ mn), Historic, 2000-2007 47
Table 32: Urinary Catheters,
United States, Overall Revenues ($ mn), Forecast, 2007-2012 48
Table 33:
Urine Bags, United States, Overall Revenues ($ mn), Historic, 2000-2007 49
Table 34: Urine Bags, United States, Overall Revenues ($ mn), Forecast,
2007-2012 50
Table 35: Incontinence Devices, United States, Overall Volume
(Units), Historic, 2000-2007 51
Table 36: Incontinence Devices, United
States, Overall Volume (Units), Forecast, 2007-2012 52
Table 37:
Protective Garments for Incontinence, United States, Overall Volume (Units),
Historic, 2000-2007 53
Table 38: Protective Garments for Incontinence,
United States, Overall Volume (Units), Forecast, 2007-2012 54
Table 39:
Urine Bags, United States, Overall Volume (Units), Historic, 2000-2007 55
Table 40: Urine Bags, United States, Overall Volume (Units), Forecast,
2007-2012 56
Table 41: Urinary Catheters, United States, Overall Volume
(Units), Historic, 2000-2007 57
Table 42: Urinary Catheters, United
States, Overall Volume (Units), Forecast, 2007-2012 58
Table 43:
Protective Garments for Incontinence, United States, Average Price ($),
Historic, 2000-2007 59
Table 44: Protective Garments for Incontinence,
United States, Average Price ($), Forecast, 2007-2012 60
Table 45: Urinary
Catheters, United States, Average Price ($), Historic, 2000-2007 61
Table
46: Urinary Catheters, United States, Average Price ($), Forecast, 2007-2012
62
Table 47: Urine Bags, United States, Average Price ($), Historic,
2000-2007 63
Table 48: Urine Bags, United States, Average Price ($),
Forecast, 2007-2012 64
Table 49: Incontinence Devices, United States,
Distribution Share by Revenue ($ mn), 2005-2006 65
Table 50: Incontinence
Devices, United States, Company Share by Revenue ($ mn), 2005-2006 66
Table 51: Renal Dialysis Equipment, United States, Overall Revenues ($ mn),
Historic, 2000-2007 67
Table 52: Renal Dialysis Equipment, United States,
Overall Revenues ($ mn), Forecast, 2007-2012 68
Table 53: Renal Dialysis
Equipment, United States, Revenue by Segment ($ mn), Historic, 2000-2007
69
Table 54: Renal Dialysis Equipment, United States, Revenue by Segment
($ mn), Forecast, 2007-2012 70
Table 55: Peritoneal Dialysis Solutions,
United States, Overall Revenues ($ mn), Historic, 2000-2007 71
Table 56:
Peritoneal Dialysis Solutions, United States, Overall Revenues ($ mn),
Forecast, 2007-2012 72
Table 57: Hemodialysis Machines, United States,
Overall Revenues ($ mn), Historic, 2000-2007 73
Table 58: Hemodialysis
Machines, United States, Overall Revenues ($ mn), Forecast, 2007-2012 74
Table 59: Continuous Renal Replacement Therapy Machines, United States,
Overall Revenues ($ mn), Historic, 2000-2007 75
Table 60: Continuous Renal
Replacement Therapy Machines, United States, Overall Revenues ($ mn),
Forecast, 2007-2012 76
Table 61: Dialysis Accessories, United States,
Overall Revenues ($ mn), Historic, 2000-2007 77
Table 62: Dialysis
Accessories, United States, Overall Revenues ($ mn), Forecast, 2007-2012
78
Table 63: Dialysis Accessories, United States, Revenue by Sub-Segment
($ mn), Historic, 2000-2007 79
Table 64: Dialysis Accessories, United
States, Revenue by Sub-Segment ($ mn), Forecast, 2007-2012 80
Table 65:
Dialyzers, United States, Overall Revenues ($ mn), Historic, 2000-2007 81
Table 66: Dialyzers, United States, Overall Revenues ($ mn), Forecast,
2007-2012 82
Table 67: Blood Tubing Sets, United States, Overall Revenues
($ mn), Historic, 2000-2007 83
Table 68: Blood Tubing Sets, United States,
Overall Revenues ($ mn), Forecast, 2007-2012 84
Table 69: Dialysis
Catheters, United States, Overall Revenues ($ mn), Historic, 2000-2007 85
Table 70: Dialysis Catheters, United States, Overall Revenues ($ mn),
Forecast, 2007-2012 86
Table 71: AV Fistula Needles, United States,
Overall Revenues ($ mn), Historic, 2000-2007 87
Table 72: AV Fistula
Needles, United States, Overall Revenues ($ mn), Forecast, 2007-2012 88
Table 73: Renal Dialysis Equipment, United States, Overall Volume (Units),
Historic, 2000-2007 89
Table 74: Renal Dialysis Equipment, United States,
Overall Volume (Units), Forecast, 2007-2012 89
Table 75: Dialysis
Accessories, United States, Overall Volume (Units), Historic, 2000-2007 90
Table 76: Dialysis Accessories, United States, Overall Volume (Units),
Forecast, 2007-2012 91
Table 77: Dialysis Accessories, United States,
Volume by Sub-Segment (Units), Historic, 2000-2007 92
Table 78: Dialysis
Accessories, United States, Volume by Sub-Segment (Units), Forecast, 2007-2012
93
Table 79: AV Fistula Needles, United States, Overall Volume (Units),
Historic, 2000-2007 94
Table 80: AV Fistula Needles, United States,
Overall Volume (Units), Forecast, 2007-2012 95
Table 81: Blood Tubing
Sets, United States, Overall Volume (Units), Historic, 2000-2007 96
Table
82: Blood Tubing Sets, United States, Overall Volume (Units), Forecast,
2007-2012 97
Table 83: Dialyzers, United States, Overall Volume (Units),
Historic, 2000-2007 98
Table 84: Dialyzers, United States, Overall Volume
(Units), Forecast, 2007-2012 99
Table 85: Dialysis Catheters, United
States, Overall Volume (Units), Historic, 2000-2007 100
Table 86: Dialysis
Catheters, United States, Overall Volume (Units), Forecast, 2007-2012 101
Table 87: Continuous Renal Replacement Therapy Machines, United States,
Overall Volume (Units), Historic, 2000-2007 102
Table 88: Continuous Renal
Replacement Therapy Machines, United States, Overall Volume (Units), Forecast,
2007-2012 103
Table 89: Hemodialysis Machines, United States, Overall
Volume (Units), Historic, 2000-2007 104
Table 90: Hemodialysis Machines,
United States, Overall Volume (Units), Forecast, 2007-2012 105
Table 91:
Hemodialysis Machines, United States, Average Price ($), Historic, 2000-2007
106
Table 92: Hemodialysis Machines, United States, Average Price ($),
Forecast, 2007-2012 107
Table 93: Continuous Renal Replacement Therapy
Machines, United States, Average Price ($), Historic, 2000-2007 108
Table 94: Continuous Renal Replacement Therapy Machines, United States,
Average Price ($), Forecast, 2007-2012 109
Table 95: Dialysis
Accessories, United States, Average Price ($), Historic, 2000-2007 110
Table 96: Dialysis Accessories, United States, Average Price ($), Forecast,
2007-2012 111
Table 97: AV Fistula Needles, United States, Average Price
($), Historic, 2000-2007 112
Table 98: AV Fistula Needles, United States,
Average Price ($), Forecast, 2007-2012 113
Table 99: Blood Tubing Sets,
United States, Average Price ($), Historic, 2000-2007 114
Table 100: Blood
Tubing Sets, United States, Average Price ($), Forecast, 2007-2012 115
Table 101: Dialysis Catheters, United States, Average Price ($), Historic,
2000-2007 116
Table 102: Dialysis Catheters, United States, Average Price
($), Forecast, 2007-2012 117
Table 103: Dialyzers, United States, Average
Price ($), Historic, 2000-2007 118
Table 104: Dialyzers, United States,
Average Price ($), Forecast, 2007-2012 119
Table 105: Renal Dialysis
Equipment, United States, Distribution Share by Revenue ($ mn), 2005-2006
120
Table 106: Renal Dialysis Equipment, United States, Company Share by
Revenue ($ mn), 2005-2006 121
Table 107: Lithotripters, United States,
Overall Revenues ($ mn), Historic, 2000-2007 122
Table 108: Lithotripters,
United States, Overall Revenues ($ mn), Forecast, 2007-2012 123
Table 109:
Lithotripters, United States, Overall Volume (Units), Historic, 2000-2007
124
Table 110: Lithotripters, United States, Overall Volume (Units),
Forecast, 2007-2012 125
Table 111: Lithotripters, United States, Average
Price ($), Historic, 2000-2007 126
Table 112: Lithotripters, United
States, Average Price ($), Forecast, 2007-2012 127
Table 113:
Lithotripters, United States, Distribution Share by Revenue ($ mn), 2005-2006
128
Table 114: Lithotripters, United States, Company Share by Revenue ($
mn), 2005-2006 129
Table 115: Baxter International Inc., SWOT
Analysis, 2006 137
Table 116: Baxter International Inc., Financial
Statements, USD Million, 2002-2006 140
Table 117: Baxter
International Inc., Financial Ratios, USD Million, 2002-2006 141
Table
118: Baxter International Inc., Other Locations 142
Table 119:
Baxter International Inc., Subsidiaries 143
Table 120: Kimberly-Clark
Corporation, SWOT Analysis, 2006 152
Table 121: Kimberly-Clark
Corporation, Financial Statements, USD Million, 2002-2006 154
Table 122:
Kimberly-Clark Corporation, Financial Ratios, USD Million, 2002-2006
155
Table 123: Kimberly-Clark Corporation, Other Locations 156
Table 124: Kimberly-Clark Corporation, Subsidiaries 156
Table 125:
Covidien Ltd./Tyco Healthcare, SWOT Analysis, 2007 164
Table 126:
Covidien Ltd./Tyco Healthcare, Financial Statements, USD Million, 2003-2007
168
Table 127: Covidien Ltd./Tyco Healthcare, Financial Ratios, USD
Million, 2003-2007 169
Table 128: Covidien Ltd./Tyco Healthcare,
Share Holding Structure 170
Table 129: Covidien Ltd./Tyco Healthcare,
Other Locations 170
Table 130: Covidien Ltd./Tyco Healthcare,
Subsidiaries 171
Table 131: C.R. Bard, Inc., SWOT Analysis, 2006
181
Table 132: C.R. Bard, Inc., Financial Statements, USD Thousand,
2002-2006 184
Table 133: C.R. Bard, Inc., Financial Ratios, USD
Thousand, 2002-2006 185
Table 134: C.R. Bard, Inc., Share Holding
Structure 186
Table 135: C.R. Bard, Inc., Other Locations 187
Table 136: C.R. Bard, Inc., Subsidiaries 188
Table 137:
Fresenius Medical Care AG & Co. KGaA, SWOT Analysis, 2007 201
Table 138:
Fresenius Medical Care AG & Co. KGaA, Financial Statements, USD Thousand,
2003-2007 205
Table 139: Fresenius Medical Care AG & Co. KGaA,
Financial Ratios, USD Thousand, 2003-2007 206
Table 140: Fresenius
Medical Care AG & Co. KGaA, Subsidiaries 207
Table 141: Medical Equipment
Registration Fee in United States, 2007 214
Table 142: Medical Device
Approval Time in United States, 2004 214
1.2 List of Figures
Figure 1: United States, Healthcare Expenditure by Source, 2003 21
Figure
2: United States, Healthcare Infrastructure, Top Level View, 2007 26
Figure 3: Healthcare Expenses Segmentation by End User, 2003 27
Figure 4:
Nephrology and Urology Devices, United States, Overall Revenues ($ mn),
2000-2012 32
Figure 5: Nephrology and Urology Devices, United States,
Overall Revenues ($ mn), Historic, 2000-2007 33
Figure 6: Nephrology and
Urology Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012
34
Figure 7: Nephrology and Urology Devices, United States, Category
Revenues ($ mn), Historic, 2000-2007 36
Figure 8: Nephrology and Urology
Devices, United States, Category Revenues ($ mn), Forecast, 2007-2012 37
Figure 9: Nephrology and Urology Devices in United States, Overall, Company
Share (%), 2006 40
Figure 10: Incontinence Devices, United States, Overall
Revenues ($ mn), Historic, 2000-2007 41
Figure 11: Incontinence Devices,
United States, Overall Revenues ($ mn), Forecast, 2007-2012 42
Figure 12:
Incontinence Devices, United States, Revenue by Segment ($ mn), Historic,
2000-2007 43
Figure 13: Incontinence Devices, United States, Revenue by
Segment ($ mn), Forecast, 2007-2012 44
Figure 14: Protective Garments for
Incontinence, United States, Overall Revenues ($ mn), Historic, 2000-2007
45
Figure 15: Protective Garments for Incontinence, United States, Overall
Revenues ($ mn), Forecast, 2007-2012 46
Figure 16: Urinary Catheters,
United States, Overall Revenues ($ mn), Historic, 2000-2007 47
Figure 17:
Urinary Catheters, United States, Overall Revenues ($ mn), Forecast, 2007-2012
48
Figure 18: Urine Bags, United States, Overall Revenues ($ mn),
Historic, 2000-2007 49
Figure 19: Urine Bags, United States, Overall
Revenues ($ mn), Forecast, 2007-2012 50
Figure 20: Incontinence Devices,
United States, Overall Volume (Units), Historic, 2000-2007 51
Figure 21:
Incontinence Devices, United States, Overall Volume (Units), Forecast,
2007-2012 52
Figure 22: Protective Garments for Incontinence, United
States, Overall Volume (Units), Historic, 2000-2007 53
Figure 23:
Protective Garments for Incontinence, United States, Overall Volume (Units),
Forecast, 2007-2012 54
Figure 24: Urine Bags, United States, Overall
Volume (Units), Historic, 2000-2007 55
Figure 25: Urine Bags, United
States, Overall Volume (Units), Forecast, 2007-2012 56
Figure 26: Urinary
catheters, United States, Overall Volume (Units), Historic, 2000-2007 57
Figure 27: Urinary Catheters, United States, Overall Volume (Units), Forecast,
2007-2012 58
Figure 28: Protective Garments for Incontinence, United
States, Average Price ($), Historic, 2000-2007 59
Figure 29: Protective
Garments for Incontinence, United States, Average Price ($), Forecast,
2007-2012 60
Figure 30: Urinary Catheters, United States, Average Price
($), Historic, 2000-2007 61
Figure 31: Urinary Catheters, United States,
Average Price ($), Forecast, 2007-2012 62
Figure 32: Urine Bags, United
States, Average Price ($), Historic, 2000-2007 63
Figure 33: Urine Bags,
United States, Average Price ($), Forecast, 2007-2012 64
Figure 34:
Incontinence Devices, United States, Distribution Share (%), 2006 65
Figure 35: Incontinence Devices, United States, Company Share (%), 2006 66
Figure 36: Renal Dialysis Equipment, United States, Overall Revenues ($ mn),
Historic, 2000-2007 67
Figure 37: Renal Dialysis Equipment, United States,
Overall Revenues ($ mn), Forecast, 2007-2012 68
Figure 38: Renal Dialysis
Equipment, United States, Revenue by Segment ($ mn), Historic, 2000-2007
69
Figure 39: Renal Dialysis Equipment, United States, Revenue by Segment
($ mn), Forecast, 2007-2012 70
Figure 40: Peritoneal Dialysis Solutions,
United States, Overall Revenues ($ mn), Historic, 2000-2007 71
Figure 41:
Peritoneal Dialysis Solutions, United States, Overall Revenues ($ mn),
Forecast, 2007-2012 72
Figure 42: Hemodialysis Machines, United States,
Overall Revenues ($ mn), Historic, 2000-2007 73
Figure 43: Hemodialysis
Machines, United States, Overall Revenues ($ mn), Forecast, 2007-2012 74
Figure 44: Continuous Renal Replacement Therapy Machines, United States,
Overall Revenues ($ mn), Historic, 2000-2007 75
Figure 45: Continuous
Renal Replacement Therapy Machines, United States, Overall Revenues ($ mn),
Forecast, 2007-2012 76
Figure 46: Dialysis Accessories, United States,
Overall Revenues ($ mn), Historic, 2000-2007 77
Figure 47: Dialysis
Accessories, United States, Overall Revenues ($ mn), Forecast, 2007-2012
78
Figure 48: Dialysis Accessories, United States, Revenue by Sub-Segment
($ mn), Historic, 2000-2007 79
Figure 49: Dialysis Accessories, United
States, Revenue by Sub-Segment ($ mn), Forecast, 2007-2012 80
Figure 50:
Dialyzers, United States, Overall Revenues ($ mn), Historic, 2000-2007 81
Figure 51: Dialyzers, United States, Overall Revenues ($ mn), Forecast,
2007-2012 82
Figure 52: Blood Tubing Sets, United States, Overall Revenues
($ mn), Historic, 2000-2007 83
Figure 53: Blood Tubing Sets, United
States, Overall Revenues ($ mn), Forecast, 2007-2012 84
Figure 54:
Dialysis Catheters, United States, Overall Revenues ($ mn), Historic,
2000-2007 85
Figure 55: Dialysis Catheters, United States, Overall
Revenues ($ mn), Forecast, 2007-2012 86
Figure 56: AV Fistula Needles,
United States, Overall Revenues ($ mn), Historic, 2000-2007 87
Figure 57:
AV Fistula Needles, United States, Overall Revenues ($ mn), Forecast,
2007-2012 88
Figure 58: Dialysis Accessories, United States, Overall
Volume (Units), Historic, 2000-2007 90
Figure 59: Dialysis Accessories,
United States, Overall Volume (Units), Forecast, 2007-2012 91
Figure 60:
Dialysis Accessories, United States, Volume by Sub-Segment (Units), Historic,
2000-2007 92
Figure 61: Dialysis Accessories, United States, Volume by
Sub-Segment (Units), Forecast, 2007-2012 93
Figure 62: AV Fistula Needles,
United States, Overall Volume (Units), Historic, 2000-2007 94
Figure 63:
AV Fistula Needles, United States, Overall Volume (Units), Forecast, 2007-2012
95
Figure 64: Blood Tubing Sets, United States, Overall Volume (Units),
Historic, 2000-2007 96
Figure 65: Blood Tubing Sets, United States,
Overall Volume (Units), Forecast, 2007-2012 97
Figure 66: Dialyzers,
United States, Overall Volume (Units), Historic, 2000-2007 98
Figure 67:
Dialyzers, United States, Overall Volume (Units), Forecast, 2007-2012 99
Figure 68: Dialysis Catheters, United States, Overall Volume (Units),
Historic, 2000-2007 100
Figure 69: Dialysis Catheters, United States,
Overall Volume (Units), Forecast, 2007-2012 101
Figure 70: Continuous
Renal Replacement Therapy Machines, United States, Overall Volume (Units),
Historic, 2000-2007 102
Figure 71: Continuous Renal Replacement Therapy
Machines, United States, Overall Volume (Units), Forecast, 2007-2012 103
Figure 72: Hemodialysis Machines, United States, Overall Volume (Units),
Historic, 2000-2007 104
Figure 73: Hemodialysis Machines, United States,
Overall Volume (Units), Forecast, 2007-2012 105
Figure 74: Hemodialysis
Machines, United States, Average Price ($), Historic, 2000-2007 106
Figure
75: Hemodialysis Machines, United States, Average Price ($), Forecast,
2007-2012 107
Figure 76: Continuous Renal Replacement Therapy Machines,
United States, Average Price ($), Historic, 2000-2007 108
Figure 77:
Continuous Renal Replacement Therapy Machines, United States, Average Price
($), Forecast, 2007-2012 109
Figure 78: Dialysis Accessories, United
States, Average Price ($), Historic, 2000-2007 110
Figure 79: Dialysis
Accessories, United States, Average Price ($), Forecast, 2007-2012 111
Figure 80: AV Fistula Needles, United States, Average Price ($), Historic,
2000-2007 112
Figure 81: AV Fistula Needles, United States, Average Price
($), Forecast, 2007-2012 113
Figure 82: Blood Tubing Sets, United States,
Average Price ($), Historic, 2000-2007 114
Figure 83: Blood Tubing Sets,
United States, Average Price ($), Forecast, 2007-2012 115
Figure 84:
Dialysis Catheters, United States, Average Price ($), Historic, 2000-2007
116
Figure 85: Dialysis Catheters, United States, Average Price ($),
Forecast, 2007-2012 117
Figure 86: Dialyzers, United States, Average Price
($), Historic, 2000-2007 118
Figure 87: Dialyzers, United States, Average
Price ($), Forecast, 2007-2012 119
Figure 88: Renal Dialysis Equipment,
United States, Distribution Share (%), 2006 120
Figure 89: Renal Dialysis
Equipment, United States, Company Share (%), 2006 121
Figure 90:
Lithotripters, United States, Overall Revenues ($ mn), Historic, 2000-2007
122
Figure 91: Lithotripters, United States, Overall Revenues ($ mn),
Forecast, 2007-2012 123
Figure 92: Lithotripters, United States, Overall
Volume (Units), Historic, 2000-2007 124
Figure 93: Lithotripters, United
States, Overall Volume (Units), Forecast, 2007-2012 125
Figure 94:
Lithotripters, United States, Average Price ($), Historic, 2000-2007 126
Figure 95: Lithotripters, United States, Average Price ($), Forecast,
2007-2012 127
Figure 96: Lithotripters, United States, Company Share (%),
2006 129
Figure 97: Baxter International Inc., Value Chain Analysis
135
Figure 98: Kimberly-Clark Corporation, Value Chain Analysis
150
Figure 99: Covidien Ltd./Tyco Healthcare, Value Chain Analysis
161
Figure 100: C.R. Bard, Inc., Value Chain Analysis 179
Figure
101: Fresenius Medical Care AG & Co. KGaA, Value Chain Analysis 199
Figu
|
Related Report
|
View Cart
